Month: September 2020

Sana Biotechnology Strengthens Senior Research Leadership Team with Ed Rebar, Ph.D. and Terry Fry, M.D.

by admin

SEATTLE—September 3, 2020 —Sana Biotechnology, Inc. (Sana), focused on creating and delivering engineered cells as medicines, announced today two additions to its senior leadership team. Ed Rebar, Ph.D., joins the company as Chief Technology Officer and Terry Fry, M.D. joins as SVP, Head of T Cell Therapeutics. “Ed and Terry are world class scientists who will […]

We use cookies to improve your experience on our website. By continuing to use this website, you agree to the use of cookies. To learn more about how we use cookies, please see our Privacy Policy.
 
Your access to, and use of, our website is subject to our Terms of Use ​and all applicable laws and regulations.  By accessing and using our website, you accept these Terms of Use.  To learn more about the Terms of Use, please visit Terms of Use.
 
ⓒ 2020-2023 Sana Biotechnology. All rights reserved.

Ok, Got it!